These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Telomere crisis, the driving force in cancer cell evolution. Ishikawa F Biochem Biophys Res Commun; 1997 Jan; 230(1):1-6. PubMed ID: 9020020 [TBL] [Abstract][Full Text] [Related]
26. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347 [TBL] [Abstract][Full Text] [Related]
27. Telomerase and human tumorigenesis. Stewart SA; Weinberg RA Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862 [TBL] [Abstract][Full Text] [Related]
28. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Artandi SE; Attardi LD Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944 [TBL] [Abstract][Full Text] [Related]
29. Protection against chromosome degradation at the telomeres. Grandin N; Charbonneau M Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802 [TBL] [Abstract][Full Text] [Related]
30. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase. Vaziri H; Benchimol S Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707 [TBL] [Abstract][Full Text] [Related]
31. In vivo regulation of telomerase activity and telomere length. Hathcock KS; Jeffrey Chiang Y; Hodes RJ Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348 [TBL] [Abstract][Full Text] [Related]
32. Telomere, telomerase, tumorigenesis and therapy: an overview. Sen S; Dasgupta A; Roychudhuri A; Mittra B; Majumder HK Indian J Exp Biol; 1999 Sep; 37(9):839-42. PubMed ID: 10687276 [TBL] [Abstract][Full Text] [Related]
33. Telomerase, checkpoints and cancer. Harley CB; Sherwood SW Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104 [TBL] [Abstract][Full Text] [Related]
34. Use of telomerase to create bioengineered tissues. Shay JW; Wright WE Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914 [TBL] [Abstract][Full Text] [Related]
35. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359 [TBL] [Abstract][Full Text] [Related]
36. Telomerase and cancer. Testorelli C J Exp Clin Cancer Res; 2003 Jun; 22(2):165-9. PubMed ID: 12866565 [TBL] [Abstract][Full Text] [Related]
37. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729 [TBL] [Abstract][Full Text] [Related]
38. Telomerase in human development and cancer. Shay JW J Cell Physiol; 1997 Nov; 173(2):266-70. PubMed ID: 9365534 [TBL] [Abstract][Full Text] [Related]
39. Telomeres and telomerase in human leukemias. Shay JW; Werbin H; Wright WE Leukemia; 1996 Aug; 10(8):1255-61. PubMed ID: 8709628 [TBL] [Abstract][Full Text] [Related]
40. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]